Immix Biopharma Analyst Ratings
Immix Biopharma Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/22/2023 | 566.67% | Roth MKM | → $14 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 02/22/2023 | 566.67% | 羅斯MKM | →$14 | 開始承保 | →購買 |
What is the target price for Immix Biopharma (IMMX)?
ImMix Biophma(IMMX)的目標價格是多少？
The latest price target for Immix Biopharma (NASDAQ: IMMX) was reported by Roth MKM on February 22, 2023. The analyst firm set a price target for $14.00 expecting IMMX to rise to within 12 months (a possible 566.67% upside). 1 analyst firms have reported ratings in the last year.
Roth MKM於2023年2月22日報道了ImMix Biophma(納斯達克：IMMX)的最新目標價。這家分析公司將目標價定為14美元，預計IMMX將在12個月內上漲至(可能上漲566.67%)。1家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Immix Biopharma (IMMX)?
ImMix Biophma(IMMX)的最新分析師評級是多少？
The latest analyst rating for Immix Biopharma (NASDAQ: IMMX) was provided by Roth MKM, and Immix Biopharma initiated their buy rating.
Roth MKM對ImMix Biophma(納斯達克代碼：IMMX)的最新分析師評級是由Roth MKM提供的，ImMix Biophma啟動了他們的買入評級。
When is the next analyst rating going to be posted or updated for Immix Biopharma (IMMX)?
IMMIX Biophma(IMMX)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Immix Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Immix Biopharma was filed on February 22, 2023 so you should expect the next rating to be made available sometime around February 22, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與ImMix Biophma的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。ImMix Biophma的最後一次評級是在2023年2月22日提交的，所以你應該預計下一次評級將在2024年2月22日左右的某個時候提供。
Is the Analyst Rating Immix Biopharma (IMMX) correct?
分析師對IMMIX Biophma(IMMX)的評級正確嗎？
While ratings are subjective and will change, the latest Immix Biopharma (IMMX) rating was a initiated with a price target of $0.00 to $14.00. The current price Immix Biopharma (IMMX) is trading at is $2.10, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的IMMIX Biophma(IMMX)評級是以0.00美元至14.00美元的目標價啟動的。ImMix Biophma(IMMX)目前的交易價格為2.10美元，在分析師的預測範圍內。